Assessment of Symptoms Control, Pulmonary Function and Related Quality of Life in Asthmatic Patients Treated with Extrafine Beclomethasone Dipropionate/Formoterol Fumarate 100/6 µg pMDI: Results of a Multicenter Observational Study in Romania (ALFRESCO Study).
J Asthma Allergy
; 15: 919-933, 2022.
Article
em En
| MEDLINE
| ID: mdl-35836969
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Guideline
/
Observational_studies
/
Qualitative_research
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article